Tower Research Capital (TRC)’s Picard Medical PMI Stock Holding History
Bought
Maintained
Sold
Other funds holding PMI
Tower Research Capital (TRC)'s PMI Position: Q3 2026 in Review
Tower Research Capital (TRC) reduced its Picard Medical (PMI) stake by 58% in Q3 2026, selling an estimated $769 and leaving 100 shares worth $420. The position accounts for ﹤0.01% of the portfolio, ranked #5577.
Tower Research Capital (TRC) first reported a position in PMI in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.02K in Q1 2026. 17 funds tracked by Wall St. Rank hold PMI as of Q3 2026.
- Tower Research Capital (TRC) held 100 shares of Picard Medical worth $420 as of Q3 2026.
- Tower Research Capital (TRC) sold 138 Picard Medical shares in Q3 2026, an estimated $769.
- Picard Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #5577 holding.
- Tower Research Capital (TRC) first reported a position in Picard Medical in Q4 2025 and has held it in 4 quarters since.
- Tower Research Capital (TRC)'s Picard Medical position peaked at $3.02K in Q1 2026.
- 17 funds tracked by Wall St. Rank held Picard Medical as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.